Literature DB >> 19620039

The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.

Gita Faghihi1, Fateme Andalib, Ali Asilian.   

Abstract

Latanoprost is an analogue of prostaglandin F(2alpha) which is used to treat glaucoma. Increases in eyelash number, thickness, and pigmentation have been reported as latanoprost side effects. The aim of this study was to evaluate if topical use of this drug can be used as a treatment of alopecia areata of eyebrows and eyelashes or not. In an experimental study, 26 patients with symmetrical eyelash and eyebrow alopecia areata were treated over 4 months with topical latanoprost for one side and the other side was not treated with any drug. The results were compared. Only one of the latanoprost-treated cases showed partial hair regrowth on the treated side. The relationship between hair regrowth and latanoprost application was not statistically significant (P = 1) by Fisher test. Based on our results, topical latanoprost has no efficacy in the treatment of alopecia areata. More studies with a larger sample size, longer study duration, and higher concentration of medication are suggested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620039     DOI: 10.1684/ejd.2009.0766

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  6 in total

1.  A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata.

Authors:  Sonali Bhat; Sanjeev Handa; Dipankar De
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

Review 2.  Alopecia areata: Part 2: treatment.

Authors:  Frank Spano; Jeff C Donovan
Journal:  Can Fam Physician       Date:  2015-09       Impact factor: 3.275

Review 3.  Eyebrow and Eyelash Alopecia: A Clinical Review.

Authors:  Betty Nguyen; Jamie Katy Hu; Antonella Tosti
Journal:  Am J Clin Dermatol       Date:  2022-10-02       Impact factor: 6.233

4.  Madarosis: a marker of many maladies.

Authors:  Annapurna Kumar; Kaliaperumal Karthikeyan
Journal:  Int J Trichology       Date:  2012-01

5.  Ruxolitinib found to cause eyelash growth: a case report.

Authors:  Julia Song; Alice Song; Trisa Palmares; Michael Song; Harold Song
Journal:  J Med Case Rep       Date:  2017-07-12

Review 6.  Female pattern alopecia: current perspectives.

Authors:  Lauren L Levy; Jason J Emer
Journal:  Int J Womens Health       Date:  2013-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.